Advanced Therapies Weekとは?

2020/3/17 Update


Advanced Therapies Week(旧:Phacilitate Leaders World & World Stem Cell Summit))は、細胞・遺伝子治療や組織工学製品の開発、投資に向けたイベントです。バイオテクノロジーから製薬会社、技術サプライヤーから投資家、規制当局、医療専門家まで、医療に興味を持つあらゆる人を対象としたイベントが開催されます。Phacilitate Leaders World、World Stem Cell Summit、Women in Advanced Therapies、ISCT Commercialization Signature Series、Stem Cell & the Regenerative Medicine In Action Awardsなど、一連の重要な科学会議が開催されます。


  • 開催地:マイアミ
  • 参加者数:
  • カンファレンス参加費用:

Phacilitate Leaders Summit 2020:1月20日〜24日 マイアミ


  • André Gerth, President & CEO, BioPlanta
  • Sadik H. Kassim, Chief Technology Officer, VOR Biopharma
  • Ashutosh Agarwal, Assistant Professor of Biomedical Engineering, Secondary Appointment of Biochemistry & Molecular Biology, マイアミ大学/University of Miami
  • Joy Aho, Senior Product Manager, Be The Match BioTherapies
  • Luca Alberici, Chief Business Officer, MolMed
  • Julie Allickson, Director, Regenerative Medicine Clinical Center, Wake Forest Regenerative Medicine Institute for Regenerative Medicine / Wake Forest School of Medicine
  • Joshua Anderson, Senior Manager, Clinical Supply Operations, Adaptimmune
  • Jane C. Andrews, Founder & CEO, Cell Bridge Strategies, LLC
  • Kyle Annen, Medical Director of Transfusion Services & Patient Blood Management, Children’s Hospital of Colorado
  • Nicole A. Aqui, M.D., Associate Professor of Clinical Pathology & Laboratory Medicine, Residency Program Director, Chief, Transfusion & Apheresis Services , Department of Pathology and Laboratory Medicine, ペンシルベニア大学付属病院/Hospital of the University of Pennsylvania
  • Anthony Atala, Professor & Director, Wake Forest Regenerative Medicine Institute, Wake Forest School of Medicine
  • Stefano Baila, Director of Operation and Business Development, Anemocyte
  • Linda S. Barnes, CEO & Founder, X-CellSystem Inc
  • Jacqueline Barry, Chief Clinical Officer, Cell & Gene Therapy Catapult
  • Oliver Bartelsen, Global Head of Business Development and Industrial Service, Miltenyi Biotec
  • Nina Bauer, COO, FloDesign Sonics
  • Douglas Beall, MD., Chief of Radiology Services, Clinical Radiology of Oklahoma, Oklahoma City
  • Pascale Belguise, Director of Business Development, Polyplus transfection
  • Reni Benjamin, Managing Director/ Biotechnology Equity Research, JMP Securities LLC
  • Alexey Bersenev, Director / Cell Therapy Labs, Yale-New Haven Hospital / Yale University
  • Barbara Binzak Blumenfeld, Shareholder, Buchanan Ingersoll & Rooney PC
  • Roberto Bolli, Chief, Division of Cardiovascular Medicine, Director Institute of Molecular Cardiology, ルイビル学/University of Louisville
  • Greg Bonfiglio, Founder & Managing Partner, Proteus, LLC
  • Breanna Borys, PhD Candidate in Biomedical Engineering, University of Calgary
  • Amandine Breton, Eu Manager, Cell Therapy Operations, Orchard Tx
  • Mike Brewer, Director, Global Principal Consultant, Regulatory, Thermo Fisher Scientific
  • Tara Britt, Associate Chair / Founder and President, NC Rare Disease Advisory Council / Rare, Disease Innovations Institute, Inc
  • James Brown, Vice President of Corporate Development, Aldevron
  • Bruce Bunnell, Professor & Director, Tulane Center for Stem Cell Research & Regenerative Medicine, Tulane University
  • Gunther Busam, Senior Director, EU CAR-T Supply Chain, Celgene
  • Melinda Caltabiano, Director, Apheresis Operations, Dendreon
  • Becky Cap, Sr Vice President and Chief Operating Officer, GenCure
  • Arnold Caplan, PhD., Professor of Biology and the Director of the Skeletal Research Center, Case Western Reserve University
  • Angelo Cardoso, Director, Laboratory of Cellular Medicine; Research Director, City of Hope Alpha Stem Cell Clinic, City of Hope Alpha Stem Cell Clinic Melissa Carpenter, PhD., Founder, The Carpenter Group